Adults and children have been flocking the Pasteur Institute in Ho Chi Minh City to seek measles vaccination as the fatalities on infected children have reached at least 123 nationwide.
A Thai research team developing an anti-malaria drug has reached the pre-clinical trial stage.
They claim the synthesis compound P218 can successfully stop the DNA of malaria parasites from forming.
This could lead to the new drug replacing pyrimethamine, the most commonly used anti-malarial, to which the disease is developing increasing resistance.
MANILA, 20 April 2014 -To mark World Immunization Week (21 to 27 April), th...